Related Experiment Video

Updated: May 13, 2025

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.6K

Revisiting REVISIT: The Case for Ceftazidime/avibactam Plus Aztreonam

Pranita D Tamma1, Thomas P Lodise2, Maria F Mojica3,4,5

  • 1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|May 12, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

6.8K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.4K

Related Experiment Videos

Last Updated: May 13, 2025

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.6K
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

6.8K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.4K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

267
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
267
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.6K

Articles linked to this work by shared authors, journal, and citation graph.

Focused Update to International Consensus Recommendations for the Use of Prolonged-Infusion Beta-Lactam Antibiotics Among Severely Ill Adult Patients: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists.

Pharmacotherapy·2026

Boronic Acid Inhibitors of β-Lactamases: A Promising Strategy Against Antimicrobial Resistance.

Medicinal research reviews·2026

Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.

Pharmacotherapy·2026

PER-14, a β-lactamase variant with reduced sensitivity to avibactam and relebactam.

Antimicrobial agents and chemotherapy·2026

Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat Pseudomonas aeruginosa clinical isolates.

JAC-antimicrobial resistance·2026

Updated Assessment of the Impact of the Modified Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Infective Endocarditis in Solid Organ and Haematopoietic Stem Cell Transplant Recipients (E-IPA Study): a propensity-score-matched retrospective cohort study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Incidence and Outcomes of Human Adenovirus Infection and Disease in a Multicenter Cohort of Pediatric Allogeneic Hematopoietic Cell Transplant Recipients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

The Rise of Natural Language Processing and the Fall of the Illness Narrative in Clinical Documentation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Isolated oculomotor nerve palsy as the sole presenting feature of neurobrucellosis: a case report.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Methicillin-resistant Staphylococcus aureus Nares Utility in Non-pneumonia Related Infections.

Clinical therapeutics·2026

Function-oriented synthesis of marine phidianidine derivatives as potent anti-MRSA agents.

Chinese journal of natural medicines·2026

Gut microbiota and metabolic profiles alteration during in vitro fecal fermentation of an immunostimulatory polysaccharide from Astragalus membranaceus.

Food research international (Ottawa, Ont.)·2026

Inappropriate Antimicrobial Prescribing Patterns and Associated Factors among Outpatients in Private Hospitals in Southwest China: A Retrospective Study (2022-2025).

Journal of global antimicrobial resistance·2026

Decreasing Treatment for Postoperative Clostridioides difficile Infection in Pediatric Surgery Patients.

Journal of pediatric surgery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us